OWL | Ophthalmic Innovation | Advancing Diversity in Leadership

OWL Membership

Learn More

Partner With Us

Learn More

Upcoming Events

Learn More
“Let’s Keep in Touch”

Sign up for access to exclusive content, events, materials and updates from OWL.

Why Join OWL?

Vision

OWL’s vision is to promote and develop diverse leadership to advance ophthalmic innovation and patient care.

Mission

OWL works across Eyecare. Our mission is to provide professional and personal development and create opportunities for collaboration.

Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!

LEARN MORE

Blog

Get Involved

Developing leaders is OWL's mission and our specialty!  Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:

  • Attend an Event
  • Submit an article for our magazine
  • Step into leadership – join an OWL Committee
  • Offer to help with a "one-time" job at one of OWL's fabulous events
  • Connect with us on social media to stay up-to-date with OWL
LEARN MORE

Support OWL

OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible.  OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).

Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications.  Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.

LEARN MORE

Owl Awards

The OWL Awards are given annually at OWL's Signature Event during AAO.  The finalists are distinguished and respected - always an impressive group!

Nominations for the OWL Awards open in the Summer.  A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.

Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.

LEARN MORE

Upcoming Programs

OWL FL Chapter: "Breaking Barriers in Ophthalmology"
6.6.24 | 5.30 PM EDT
Stonewood Grill & Tavern
5415 University Pkwy
University Park, FL 34201
OWL at AECOS European Symposium
6.7.24 | 5 PM
Hotel Don Giovanni Prague
Prague, Czech Republic
OWL St. Louis Networking Event
6.13.24 | 4.30 PM CDT
The Boundary at The Cheshire
7036 Clayton Avenue #1915
St. Louis, MO, 63117
OWL SoCal Program at Octane's OTF "The Future of Work in Eyecare: Talent, Collaboration and Innovation"
6.20.24 | 4.30 PM PDT
VEA Newport Beach
(Monaco Room)
900 Newport Center Dr
Newport Beach, CA 92660
OWL Summer Reception at AECOS
7.13.24 | 5.30 PM MDT
The Library, St Regis Hotel
2300 Deer Valley Dr E
Park City, UT 84060
OWL Leadership Summit
9.26-9.27.24
Hyatt Centric French Quarter
800 Iberville St
New Orleans, LA 70112

Featured Champion Members

Ana Neves

Head of Strategic Marketing
Global Strategic Marketing Ophthalmology
ZEISS Medical Technology

Ana Neves is the Head of Global Strategic Marketing for ZEISS Medical Technology’s Ophthalmic business, one of the world's leading medical technology companies. With more than 20 years of corporate leadership at top multi-national healthcare companies, Ana is recognized as a transformational leader for developing innovative commercial market strategies and building strong professional relationships that are foundational to driving market demand and customer value in the healthcare sector. She is a highly respected B2B and B2C marketing visionary, widely acknowledged for her inspirational executive leadership, creative campaigns, business acumen and data-driven strategic management. Recent career highlights include her leadership in bringing the ZEISS Medical Ecosystem to life as the cornerstone for digitally connected workflow solutions across the field of ophthalmology.

Ana is passionate about commercial excellence and has earned a reputation for cultivating deep customer connections, delivering strong results and building high-performance teams. Described as a progressive, approachable and empathic leader, Ana understands the critical importance of diversity and inclusion, as well as mentoring people in their professional development. Ana easily navigates complex issues and flourishes in change management. She relishes in bringing a clear, strategic marketing vision to life in the pursuit of driving profitable growth. With a deep commitment to transparency, fairness and ethical business practices, she inspires and motivates teams and peers alike to perform at their best.

Ana was born and raised in Portugal, and currently resides in Berlin, Germany. She received a Master’s of Science degree in Pharmacy from the University of Lisbon, and her MBA from the Universidade Católica Portuguesa (UCP). She worked and lived for five years in South-East Asia, predominately in Singapore and Malaysia, where she worked in sales and P&L management leadership positions.

More OWL Champions
Jay Duker, MD

President & CEO and Board Director
EyePoint Pharmaceuticals

Jay S. Duker, MD, is the President & Chief Executive Officer of EyePoint Pharmaceuticals, a biotech company that develops sustained-release medications to treat serious ocular disorders. Prior to becoming CEO in 2023, Dr. Duker was EyePoint’s Chief Operating Officer from 2022-2023 and the Chief Strategic Scientific Officer from 2020-2022. He served on EyePoint’s Board of Directors from 2016-2020.

For the 21 years between 2001 and 2021, Dr. Duker served as the Director of the New England Eye Center (NEEC) and Professor and Chair of the Department of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine in Boston, Massachusetts. He has published over 350 peer-reviewed papers and as served as editor of multiple text books including Yanoff and Duker’s Ophthalmology, one of the best selling books in ophthalmology over the past three decades, now in its sixth edition.

Dr. Duker is the founder of three successful start-up companies; SurgiSite Boston, the Boston Image Reading Center (BIRC), and Hemera Biosciences, the developer of HMR59, an AAV-based gene therapy for dry age-related macular degeneration that is now in a ph2 clinical trial after being acquired by Janssen in 2020.

More OWL Champions